Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: Comparative mRNA expression analysis of RAGE and GAGE genes

Acta Oto-Laryngologica

Volumn 122, Issue 5, 2002, Pages 546-552

  Gotte K ^a   Usener, D ^b   Riedel, F ^a   Hormann K ^a   Schadendorf, D ^b   Eichmuller S ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

GAGE; Head and neck cancer; RAGE; Specific immune therapy; Tumor associated antigens

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN GAGE; PROTEIN GAGE 1; PROTEIN GAGE 2; PROTEIN GAGE 3; PROTEIN GAGE 4; PROTEIN GAGE 5; PROTEIN GAGE 6; PROTEIN GAGE 7; PROTEIN GAGE 8; PROTEIN RAGE; PROTEIN RAGE 1; PROTEIN RAGE 2; PROTEIN RAGE 3; PROTEIN RAGE 4; TUMOR ANTIGEN; UNCLASSIFIED DRUG; EYE PROTEIN; GAGE1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; RAGE PROTEIN, HUMAN; TUMOR PROTEIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; GENE EXPRESSION REGULATION; GENE SEGREGATION; GENE TARGETING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CANCER; IMMUNOPATHOLOGY; LARYNX CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SQUAMOUS CELL CARCINOMA; COMPARATIVE STUDY; GENETICS; HEAD AND NECK TUMOR; IMMUNOLOGY; IMMUNOTHERAPY; NORTHERN BLOTTING;

ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; EYE PROTEINS; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOTHERAPY; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 0035994987     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480260092381     Document Type: Article

References (25)

1. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
2. Dendritic cell vaccination for cancer therapy
3. Progress in human tumour immunology and immunotherapy
4. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
5. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
6. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
7. Human tumor antigens recognized by T lymphocytes
8. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
9. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
10. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
11. Characterization of human colon cancer antigens recognized by autologous antibodies
12. Isoforms of the human PDZ-73 protein exhibit differential tissue expression
13. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
14. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma
15. mRNA expression of tumor-associated antigens in melanoma tissues and cell lines
16. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis
17. Molecular cloning and characterization of a novel member of the MAP kinase superfamily
18. Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method
19. MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas
20. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus
21. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens
22. MAGE, BAGE and GAGE: Tumour antigen expression in benign and malignant ovarian tumors ovarian tissue
23. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: Candidates for T-cell-based immunotherapies?
24. Expression of MAGE and GAGE in high-grade brain tumors: A potential target for specific immunotherapy and diagnostic markers
25. Tumor antigens recognized by T lymphocytes